| 1 |
任成山，杨仕明，晋献春，等. 何谓H7N9禽流感——应正确认识和积极防治[J/CD]. 中华肺部疾病杂志(电子版), 2013, 6(2): 76-78.
|
| 2 |
Wang QM, Liu SL, Chen EF. [Advances on epidemiological research of human infections with novel avian influenza A (H7N9) virus][J]. Zhonghua Yu Fang Yi Xue Za Zhi, 2017, 51(2): 183-187.
|
| 3 |
Dai M, McBride R, Dortmans JC, et al. Mutation of the 2<sup>nd</sup> Sialic Acid-Binding Site Resulting in Reduced Neuraminidase Activity Preceded Emergence of H7N9 Influenza A Virus[J]. J Virol, 2017, doi: 10.1128/JVI.00049-17. |
| 4 |
Nie Q, Zhang DY, Wu WJ, et al. Extracorporeal membrane oxygenation for avian influenza A (H7N9) patient with acute respiratory distress syndrome: a case report and short literature review[J]. BMC Pulm Med, 2017, 17(1): 38.
|
| 5 |
任成山，钱桂生. 甲型H1N1流感的流行特点及防控对策[J]. 中华医学杂志，2009, 89(46): 3241-3243.
|
| 6 |
Bertram S, Thiele S, Dreier C, et al. H7N9 Influenza A Virus Exhibits Importin-α7-Mediated Replication in the Mammalian Respiratory Tract[J]. Am J Pathol, 2017, doi: 10.1016/j.ajpath.2016.12.017. |
| 7 |
Barman S, Krylov PS, Turner JC, et al. Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs[J]. Vaccine, 2017, doi: 10.1016/j.vaccine.2017.01.061. |
| 8 |
Hu CJ, Chien CY, Liu MT, et al. Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models[J]. BMC Biotechnol, 2017, 17(1): 2.
|
| 9 |
Wang MX, Yuan MQ, Fang Y. [Research on spatiotemporal spread of avian influenza A(H7N9) virus based on discrete geographic information] [J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2016, 37(11): 1491-1496.
|
| 10 |
Ge E, Zhang R, Li D, et al. Estimating Risks of Inapparent Avian Exposure for Human Infection: Avian Influenza Virus A (H7N9) in Zhejiang Province, China[J]. Sci Rep, 2017, 7: 40016.
|